U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 4811

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:8941823-13442041
GRCh38:
Chr19:8831147-13331227
ACP5, ANGPTL6, ANGPTL8, AP1M2, ATG4D, BEST2, C19orf38, CACNA1A, CALR, CARM1, CCDC159, CDC37, CDKN2D, CNN1, COL5A3, DAND5, DHPS, DNASE2, DNM2, DNMT1, DOCK6, ECSIT, EIF3G, ELAVL3, ELOF1, EPOR, FARSA, FARSA-AS1, FBXL12, FBXW9, FDX2, FDX2-ZGLP1, GADD45GIP1, GCDH, GET3, GNG14, HOOK2, ICAM1, ICAM3, ICAM4, ICAM5, IER2, ILF3, ILF3-DT, JUNB, KANK2, KEAP1, KLF1, KRI1, LDLR, LDLR-AS1, LIMASI, LINC02926, LOC100505555, LOC105372273, LOC107080555, LOC108663985, LOC110121441, LOC110121458, LOC112543445, LOC112543446, LOC112543448, LOC112543452, LOC112543454, LOC112543455, LOC112543458, LOC113939967, LOC116276501, LOC116276502, LOC116276503, LOC117038783, LOC117038784, LOC117038785, LOC117038786, LOC117038787, LOC117038788, LOC117038789, LOC117038790, LOC117038791, LOC117038792, LOC117038793, LOC117038794, LOC117038795, LOC117125585, LOC117125586, LOC117125587, LOC117125588, LOC117125589, LOC117125590, LOC117125591, LOC117125592, LOC117125593, LOC117125594, LOC117125595, LOC117125596, LOC117125597, LOC117125598, LOC121852977, LOC121852978, LOC121852979, LOC121852980, LOC125371473, LOC125371474, LOC125371475, LOC125371476, LOC125371477, LOC125371478, LOC125371479, LOC125371480, LOC125371481, LOC126862848, LOC126862849, LOC126862850, LOC126862851, LOC126862852, LOC126862853, LOC126862854, LOC126862855, LOC126862856, LOC126862857, LOC126862858, LOC126862859, LOC126862860, LOC126862861, LOC126862862, LOC126862863, LOC126862864, LOC126862865, LOC648044, LYL1, MAN2B1, MAST1, MBD3L1, MIR1181, MIR1238, MIR199A1, MIR4322, MIR4748, MIR5589, MIR5684, MIR5695, MIR638, MIR6515, MIR6793, MIR6794, MIR6886, MIR7974, MRPL4, MUC16, NACC1, NFIX, ODAD3, OLFM2, OR1M1, OR7D2, OR7D4, OR7E24, OR7G1, OR7G2, OR7G3, P2RY11, PDE4A, PIN1, PIN1-DT, PLPPR2, PPAN, PPAN-P2RY11, PRDX2, PRKCSH, QTRT1, RAB3D, RAD23A, RAVER1, RDH8, RGL3, RNASEH2A, RTBDN, S1PR2, S1PR5, SHFL, SLC44A2, SMARCA4, SNORD105, SNORD105B, SNORD135, SNORD41, SPC24, STX10, SWSAP1, SYCE2, THSD8, TIMM29, TMED1, TMEM205, TNPO2, TRIR, TRMT1, TSPAN16, TYK2, UBL5, WDR83, WDR83OS, YIPF2, ZGLP1, ZNF121, ZNF136, ZNF177, ZNF20, ZNF266, ZNF317, ZNF426, ZNF426-DT, ZNF433, ZNF433-AS1, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442, ZNF443, ZNF490, ZNF491, ZNF558, ZNF559, ZNF559-ZNF177, ZNF560, ZNF561, ZNF561-AS1, ZNF562, ZNF563, ZNF564, ZNF625, ZNF625-ZNF20, ZNF627, ZNF653, ZNF69, ZNF699, ZNF700, ZNF709, ZNF763, ZNF791, ZNF799, ZNF823, ZNF844, ZNF846, ZNF878
See casesLikely pathogenic
(May 6, 2011)
no assertion criteria provided
2.
GRCh37:
Chr19:9846119-11338677
GRCh38:
Chr19:9735443-11228001
See casesPathogenic
(Jul 30, 2009)
no assertion criteria provided
3.
GRCh37:
Chr19:10425934-14159806
GRCh38:
Chr19:10315258-14048994
ACP5, ANGPTL8, AP1M2, ATG4D, BEST2, BRME1, C19orf38, C19orf53, CACNA1A, CALR, CARM1, CC2D1A, CCDC159, CDC37, CDKN2D, CNN1, DAND5, DCAF15, DHPS, DNASE2, DNM2, DOCK6, ECSIT, ELAVL3, ELOF1, EPOR, FARSA, FARSA-AS1, FBXW9, FDX2, FDX2-ZGLP1, GADD45GIP1, GCDH, GET3, GNG14, HOOK2, ICAM3, IER2, IL27RA, ILF3, ILF3-DT, JUNB, KANK2, KEAP1, KLF1, KRI1, LDLR, LDLR-AS1, LINC02926, LOC105372273, LOC108663985, LOC110121441, LOC110121458, LOC111365163, LOC112543445, LOC112543446, LOC112543448, LOC112543452, LOC112543454, LOC112543455, LOC112543458, LOC112543459, LOC116276503, LOC116276504, LOC116276505, LOC117038783, LOC117038784, LOC117038785, LOC117038786, LOC117038787, LOC117038788, LOC117038789, LOC117038790, LOC117038791, LOC117038792, LOC117038793, LOC117038794, LOC117038795, LOC117125585, LOC117125586, LOC117125587, LOC117125588, LOC117125589, LOC117125590, LOC117125591, LOC117125592, LOC117125593, LOC117125594, LOC117125595, LOC117125596, LOC117125597, LOC117125598, LOC121852977, LOC121852978, LOC121852979, LOC121852980, LOC121852981, LOC125371477, LOC125371478, LOC125371479, LOC125371480, LOC125371481, LOC126862855, LOC126862856, LOC126862857, LOC126862858, LOC126862859, LOC126862860, LOC126862861, LOC126862862, LOC126862863, LOC126862864, LOC126862865, LOC126862866, LOC648044, LYL1, MAN2B1, MAST1, MIR1181, MIR1238, MIR181C, MIR181D, MIR199A1, MIR23A, MIR23AHG, MIR24-2, MIR27A, MIR4748, MIR5684, MIR5695, MIR638, MIR6515, MIR6793, MIR6794, MIR6886, MIR7974, MRI1, NACC1, NANOS3, NFIX, ODAD3, PDE4A, PLPPR2, PODNL1, PRDX2, PRKCSH, QTRT1, RAB3D, RAD23A, RAVER1, RFX1, RGL3, RLN3, RNASEH2A, RTBDN, S1PR5, SLC44A2, SMARCA4, SNORD135, SNORD41, SPC24, STX10, SWSAP1, SYCE2, THSD8, TIMM29, TMED1, TMEM205, TNPO2, TRIR, TRMT1, TSPAN16, TYK2, WDR83, WDR83OS, YIPF2, YJU2B, ZNF136, ZNF20, ZNF433, ZNF433-AS1, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442, ZNF443, ZNF490, ZNF491, ZNF563, ZNF564, ZNF625, ZNF625-ZNF20, ZNF627, ZNF653, ZNF69, ZNF700, ZNF709, ZNF763, ZNF791, ZNF799, ZNF823, ZNF844, ZNF878, ZSWIM4
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh37:
Chr19:10430150-13888674
GRCh38:
Chr19:10319474-13777860
ACP5, ANGPTL8, AP1M2, ATG4D, BEST2, C19orf38, C19orf53, CACNA1A, CALR, CARM1, CCDC159, CDC37, CDKN2D, CNN1, DAND5, DHPS, DNASE2, DNM2, DOCK6, ECSIT, ELAVL3, ELOF1, EPOR, FARSA, FARSA-AS1, FBXW9, GADD45GIP1, GCDH, GET3, GNG14, HOOK2, ICAM3, IER2, ILF3, ILF3-DT, JUNB, KANK2, KEAP1, KLF1, KRI1, LDLR, LDLR-AS1, LINC02926, LOC105372273, LOC108663985, LOC110121441, LOC110121458, LOC111365163, LOC112543445, LOC112543446, LOC112543448, LOC112543452, LOC112543454, LOC112543455, LOC112543458, LOC112543459, LOC116276503, LOC117038783, LOC117038784, LOC117038785, LOC117038786, LOC117038787, LOC117038788, LOC117038789, LOC117038790, LOC117038791, LOC117038792, LOC117038793, LOC117038794, LOC117038795, LOC117125585, LOC117125586, LOC117125587, LOC117125588, LOC117125589, LOC117125590, LOC117125591, LOC117125592, LOC117125593, LOC117125594, LOC117125595, LOC117125596, LOC117125597, LOC117125598, LOC121852977, LOC121852978, LOC121852979, LOC121852980, LOC121852981, LOC125371477, LOC125371478, LOC125371479, LOC125371480, LOC125371481, LOC126862855, LOC126862856, LOC126862857, LOC126862858, LOC126862859, LOC126862860, LOC126862861, LOC126862862, LOC126862863, LOC126862864, LOC126862865, LOC126862866, LOC648044, LYL1, MAN2B1, MAST1, MIR1181, MIR1238, MIR199A1, MIR4748, MIR5684, MIR5695, MIR638, MIR6515, MIR6793, MIR6794, MIR6886, MIR7974, MRI1, NACC1, NFIX, ODAD3, PDE4A, PLPPR2, PRDX2, PRKCSH, QTRT1, RAB3D, RAD23A, RAVER1, RGL3, RNASEH2A, RTBDN, S1PR5, SLC44A2, SMARCA4, SNORD135, SNORD41, SPC24, STX10, SWSAP1, SYCE2, THSD8, TIMM29, TMED1, TMEM205, TNPO2, TRIR, TRMT1, TSPAN16, TYK2, WDR83, WDR83OS, YIPF2, YJU2B, ZNF136, ZNF20, ZNF433, ZNF433-AS1, ZNF439, ZNF44, ZNF440, ZNF441, ZNF442, ZNF443, ZNF490, ZNF491, ZNF563, ZNF564, ZNF625, ZNF625-ZNF20, ZNF627, ZNF653, ZNF69, ZNF700, ZNF709, ZNF763, ZNF791, ZNF799, ZNF823, ZNF844, ZNF878
See casesPathogenic
(Oct 1, 2010)
no assertion criteria provided
5.
GRCh37:
Chr19:11071560
GRCh38:
Chr19:10960884
SMARCA4not providedBenign
(Jun 18, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr19:11071810
GRCh38:
Chr19:10961134
SMARCA4Coffin-Siris syndromeLikely benign
(Apr 27, 2017)
criteria provided, single submitter
7.
GRCh37:
Chr19:11071839
GRCh38:
Chr19:10961163
SMARCA4Coffin-Siris syndrome, not providedLikely benign
(Mar 28, 2018)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr19:11071861
GRCh38:
Chr19:10961185
SMARCA4Coffin-Siris syndromeUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
9.
GRCh37:
Chr19:11071879
GRCh38:
Chr19:10961203
SMARCA4not providedBenign
(Jun 1, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr19:11071884
GRCh38:
Chr19:10961208
SMARCA4Rhabdoid tumor predisposition syndrome 2Uncertain significance
(May 28, 2019)
criteria provided, single submitter
11.
GRCh37:
Chr19:11071918
GRCh38:
Chr19:10961242
SMARCA4not providedLikely benign
(Jul 8, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr19:11094591
GRCh38:
Chr19:10983915
SMARCA4not providedLikely benign
(Jun 23, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr19:11094789
GRCh38:
Chr19:10984113
SMARCA4not providedUncertain significance
(Feb 12, 2020)
criteria provided, single submitter
14.
GRCh37:
Chr19:11094791
GRCh38:
Chr19:10984115
SMARCA4Hereditary cancer-predisposing syndromeUncertain significance
(Feb 15, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr19:11094797-11172958
GRCh38:
Chr19:10984121-11062282
SMARCA4Rhabdoid tumor predisposition syndrome 2Pathogenic
(Oct 24, 2016)
criteria provided, single submitter
16.
GRCh37:
Chr19:11094818-11107066
GRCh38:
Chr19:10984142-10996390
SMARCA4Rhabdoid tumor predisposition syndrome 2Uncertain significance
(May 14, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr19:11094823
GRCh38:
Chr19:10984147
SMARCA4Hereditary cancer-predisposing syndromeUncertain significance
(Oct 29, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr19:11094830
GRCh38:
Chr19:10984154
SMARCA4M1INeurodevelopmental disorder, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr19:11094833
GRCh38:
Chr19:10984157
SMARCA4Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome, not specified
Likely benign
(Apr 22, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr19:11094834
GRCh38:
Chr19:10984158
SMARCA4T3ARhabdoid tumor predisposition syndrome 2Uncertain significance
(May 4, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr19:11094834
GRCh38:
Chr19:10984158
SMARCA4T3PIntellectual disability, autosomal dominant 16, Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 24, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr19:11094835
GRCh38:
Chr19:10984159
SMARCA4T3NHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr19:11094835
GRCh38:
Chr19:10984159
SMARCA4T3IHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(May 7, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr19:11094836
GRCh38:
Chr19:10984160
SMARCA4Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeLikely benign
(May 24, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr19:11094837
GRCh38:
Chr19:10984161
SMARCA4P4ARhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeUncertain significance
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr19:11094837
GRCh38:
Chr19:10984161
SMARCA4P4SRhabdoid tumor predisposition syndrome 2, not providedUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr19:11094838
GRCh38:
Chr19:10984162
SMARCA4P4QHereditary cancer-predisposing syndromeUncertain significance
(Mar 17, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr19:11094840
GRCh38:
Chr19:10984164
SMARCA4D5HHereditary cancer-predisposing syndromeUncertain significance
(Feb 14, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr19:11094842
GRCh38:
Chr19:10984166
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Aug 12, 2021)
criteria provided, single submitter
30.
GRCh37:
Chr19:11094844
GRCh38:
Chr19:10984168
SMARCA4P6QRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr19:11094846
GRCh38:
Chr19:10984170
SMARCA4P7TRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 16, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr19:11094847
GRCh38:
Chr19:10984171
SMARCA4P7RHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 26, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr19:11094847
GRCh38:
Chr19:10984171
SMARCA4P7HHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16
Uncertain significance
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr19:11094848
GRCh38:
Chr19:10984172
SMARCA4Hereditary cancer-predisposing syndromeLikely benign
(Nov 4, 2020)
criteria provided, single submitter
35.
GRCh37:
Chr19:11094848
GRCh38:
Chr19:10984172
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Apr 8, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr19:11094849
GRCh38:
Chr19:10984173
SMARCA4L8MHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Jun 15, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr19:11094849
GRCh38:
Chr19:10984173
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Aug 3, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr19:11094851
GRCh38:
Chr19:10984175
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Jan 1, 2020)
criteria provided, single submitter
39.
GRCh37:
Chr19:11094851
GRCh38:
Chr19:10984175
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Jul 4, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr19:11094852
GRCh38:
Chr19:10984176
SMARCA4G9SHereditary cancer-predisposing syndromeUncertain significance
(Nov 3, 2016)
criteria provided, single submitter
41.
GRCh37:
Chr19:11094853
GRCh38:
Chr19:10984177
SMARCA4G9DHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr19:11094854
GRCh38:
Chr19:10984178
SMARCA4Hereditary cancer-predisposing syndromeLikely benign
(Mar 11, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr19:11094854
GRCh38:
Chr19:10984178
SMARCA4Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeLikely benign
(Jul 21, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr19:11094854
GRCh38:
Chr19:10984178
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr19:11094855
GRCh38:
Chr19:10984179
SMARCA4G10RRhabdoid tumor predisposition syndrome 2Uncertain significance
(Oct 14, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr19:11094858
GRCh38:
Chr19:10984182
SMARCA4T11ARhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome
Uncertain significance
(Feb 21, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr19:11094859
GRCh38:
Chr19:10984183
SMARCA4T11SRhabdoid tumor predisposition syndrome 2Uncertain significance
(Dec 9, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr19:11094859
GRCh38:
Chr19:10984183
SMARCA4T11IHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Jun 3, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr19:11094860
GRCh38:
Chr19:10984184
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(May 16, 2017)
criteria provided, single submitter
50.
GRCh37:
Chr19:11094861
GRCh38:
Chr19:10984185
SMARCA4P12SHereditary cancer-predisposing syndromeUncertain significance
(Oct 14, 2020)
criteria provided, single submitter
51.
GRCh37:
Chr19:11094862
GRCh38:
Chr19:10984186
SMARCA4P12LIntellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2
Uncertain significance
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr19:11094863
GRCh38:
Chr19:10984187
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(May 13, 2019)
criteria provided, single submitter
53.
GRCh37:
Chr19:11094864
GRCh38:
Chr19:10984188
SMARCA4Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr19:11094864
GRCh38:
Chr19:10984188
SMARCA4R13WHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Jul 10, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr19:11094865
GRCh38:
Chr19:10984189
SMARCA4R13LRhabdoid tumor predisposition syndrome 2Uncertain significance
(Feb 19, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr19:11094865
GRCh38:
Chr19:10984189
SMARCA4R13PHereditary cancer-predisposing syndromeUncertain significance
(Aug 27, 2020)
criteria provided, single submitter
57.
GRCh37:
Chr19:11094865
GRCh38:
Chr19:10984189
SMARCA4R13QIntellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2
Uncertain significance
(Apr 7, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr19:11094866
GRCh38:
Chr19:10984190
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:11094866
GRCh38:
Chr19:10984190
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr19:11094867-11094868
GRCh38:
Chr19:10984191-10984192
SMARCA4P14ERhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr19:11094867
GRCh38:
Chr19:10984191
SMARCA4P14THereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Mar 29, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr19:11094869
GRCh38:
Chr19:10984193
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Apr 16, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr19:11094869
GRCh38:
Chr19:10984193
SMARCA4Hereditary cancer-predisposing syndromeLikely benign
(Jan 14, 2019)
criteria provided, single submitter
64.
GRCh37:
Chr19:11094871
GRCh38:
Chr19:10984195
SMARCA4G15DHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Apr 30, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr19:11094871
GRCh38:
Chr19:10984195
SMARCA4G15AHereditary cancer-predisposing syndromeUncertain significance
(Feb 7, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr19:11094871
GRCh38:
Chr19:10984195
SMARCA4G15VRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr19:11094874
GRCh38:
Chr19:10984198
SMARCA4P16RHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Uncertain significance
(Jun 9, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr19:11094877
GRCh38:
Chr19:10984201
SMARCA4S17FRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr19:11094878
GRCh38:
Chr19:10984202
SMARCA4Hereditary cancer-predisposing syndromeLikely benign
(Oct 6, 2020)
criteria provided, single submitter
70.
GRCh37:
Chr19:11094878
GRCh38:
Chr19:10984202
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Nov 21, 2019)
criteria provided, single submitter
71.
GRCh37:
Chr19:11094878
GRCh38:
Chr19:10984202
SMARCA4Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeLikely benign
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr19:11094880
GRCh38:
Chr19:10984204
SMARCA4P18LHereditary cancer-predisposing syndrome, Intellectual disability, autosomal dominant 16, not provided,
Rhabdoid tumor predisposition syndrome 2
Conflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr19:11094881
GRCh38:
Chr19:10984205
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Nov 2, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr19:11094881
GRCh38:
Chr19:10984205
SMARCA4Intellectual disability, autosomal dominant 16, Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr19:11094883
GRCh38:
Chr19:10984207
SMARCA4G19ARhabdoid tumor predisposition syndrome 2Uncertain significance
(Nov 15, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr19:11094884
GRCh38:
Chr19:10984208
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Oct 27, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr19:11094884
GRCh38:
Chr19:10984208
SMARCA4Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeLikely benign
(Jan 28, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr19:11094890
GRCh38:
Chr19:10984214
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Aug 22, 2020)
criteria provided, single submitter
79.
GRCh37:
Chr19:11094891
GRCh38:
Chr19:10984215
SMARCA4P22ARhabdoid tumor predisposition syndrome 2Uncertain significance
(May 30, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr19:11094891
GRCh38:
Chr19:10984215
SMARCA4P22SRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr19:11094892
GRCh38:
Chr19:10984216
SMARCA4P22HIntellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2
Uncertain significance
(Feb 22, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr19:11094892
GRCh38:
Chr19:10984216
SMARCA4P22LHereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16
Uncertain significance
(May 12, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr19:11094892
GRCh38:
Chr19:10984216
SMARCA4P22RRhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr19:11094893
GRCh38:
Chr19:10984217
SMARCA4Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndromeLikely benign
(May 24, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr19:11094895
GRCh38:
Chr19:10984219
SMARCA4S23FRhabdoid tumor predisposition syndrome 2Uncertain significance
(Nov 8, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr19:11094895
GRCh38:
Chr19:10984219
SMARCA4S23CRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr19:11094895
GRCh38:
Chr19:10984219
SMARCA4S23YHereditary cancer-predisposing syndromeUncertain significance
(Feb 16, 2017)
criteria provided, single submitter
88.
GRCh37:
Chr19:11094896
GRCh38:
Chr19:10984220
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Mar 12, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr19:11094896
GRCh38:
Chr19:10984220
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr19:11094897-11094926
GRCh38:
Chr19:10984221-10984250
SMARCA4Hereditary cancer-predisposing syndromeUncertain significance
(Nov 4, 2020)
criteria provided, single submitter
91.
GRCh37:
Chr19:11094897
GRCh38:
Chr19:10984221
SMARCA4P24SRhabdoid tumor predisposition syndrome 2Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr19:11094897
GRCh38:
Chr19:10984221
SMARCA4P24Anot provided, Hereditary cancer-predisposing syndrome, Intellectual disability, autosomal dominant 16,
Rhabdoid tumor predisposition syndrome 2
Uncertain significance
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr19:11094898
GRCh38:
Chr19:10984222
SMARCA4P24RRhabdoid tumor predisposition syndrome 2, Intellectual disability, autosomal dominant 16, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr19:11094899
GRCh38:
Chr19:10984223
SMARCA4Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2Likely benign
(Jun 26, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr19:11094900
GRCh38:
Chr19:10984224
SMARCA4G25RRhabdoid tumor predisposition syndrome 2Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr19:11094900-11094902
GRCh38:
Chr19:10984224-10984226
SMARCA4G25delRhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome, Intellectual disability, autosomal dominant 16
Uncertain significance
(Jul 21, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr19:11094902
GRCh38:
Chr19:10984226
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Oct 7, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr19:11094902
GRCh38:
Chr19:10984226
SMARCA4Rhabdoid tumor predisposition syndrome 2Likely benign
(Nov 21, 2019)
criteria provided, single submitter
99.
GRCh37:
Chr19:11094903
GRCh38:
Chr19:10984227
SMARCA4A26PHereditary cancer-predisposing syndromeUncertain significance
(Sep 20, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr19:11094903
GRCh38:
Chr19:10984227
SMARCA4A26Tnot provided, Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2,
Intellectual disability, autosomal dominant 16
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination